About OTCPharm
OTCPharm is a company based in Moscow (Russia) founded in 2013. OTCPharm offers products and services including Afobazol and Rinostop.
- Headquarter Moscow, Russia
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ао 'Отисифарм'
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OTCPharm
OTCPharm offers a comprehensive portfolio of products and services, including Afobazol and Rinostop.
Afobazol is utilized as an over-the-counter anti-anxiety preparation that is administered once daily, with its effects noted for managing anxiety symptoms.
Rinostop is employed for relieving nasal congestion, where various formulations are provided to address breathing difficulties and promote mucosal healing.
Funding Insights of OTCPharm
Investments & Acquisitions by OTCPharm
Financial Statements - OTCPharm
Otcpharm Comparisons
Competitors of OTCPharm
Latest news on Otcpharm
Frequently Asked Questions about OTCPharm
OTCPharm was founded in 2013.
OTCPharm is headquartered in Moscow, Russia.
Olga Mednikova is the current CEO of OTCPharm.
OTCPharm was established in 2013 through the reorganization of Pharmstandard, a Russian pharmaceutical entity. Operations are centered in the OTC sector of the Russian pharmaceutical industry, with a portfolio encompassing over-the-counter medications and select prescription drugs across multiple therapeutic categories. Four manufacturing facilities are operated from Moscow, Russia, supporting distribution within the domestic market.
OTCPharm offers Afobazol and Rinostop.